HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
CGP 35949
Also Known As:
CGP-35949; N-(3-(3-(4-acetyl-3-hydroxy-2-n-propylphenoxy)propoxy)-4-chloro-6-methylphenyl)-1H-tetrazole-5-carboxamide
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Azoles: 2138
Tetrazoles: 14
CGP 35949: 2
Related Diseases
1.
Wounds and Injuries (Trauma)
05/01/1987 - "
CGP 33304 and CGP 35949 both significantly (p less than 0.01) attenuated the accumulation of MDF activity in the plasma (24 +/- 3 and 29 +/- 3 U/ml, respectively, vs. 57 +/- 5 U/ml in the trauma and vehicle group).
"
2.
Traumatic Shock
05/01/1987 - "
CGP 33304 and CGP 35949 may, therefore, prove to be useful therapeutic agents in acute ischemic disorders including traumatic shock.
"
05/01/1987 - "
The effects of CGP 33304 and CGP 35949 were studied in standardized model of traumatic shock.
"
3.
Asthma (Bronchial Asthma)
01/01/1987 - "
CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma.
"
Related Drugs and Biologics
1.
Leukotriene D4
2.
Phospholipases (Phospholipase)
3.
milk-derived factor
4.
CGP 33304